At a glance

ClinicalIndex Comparison Record

Phase 4Completed· 32 enrolled

Drug / intervention

Caffeine +1 moredietary

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02825199

NCT02825199Phase 4Completed

Compare CT.gov

Effect of Caffeine Intake in Vestibular Function: A Randomized Triple-Blind Controlled Trial

Instituto Brasiliense de Otorrinolaringologia·interventional·Posted Jul 7, 2016·Updated Jul 7, 2016

In Brief

A Phase 4 clinical trial evaluating Caffeine and Non caffeine for Vertigo and 2 related conditions. Completed, enrolled 32 participants across 1 site.

Detailed Summary

Objective: Assess the effect of caffeine in the following vestibular function tests: Cervical Vestibular Evoked Potential (cVEMP), Ocular Vestibular Evoked Potential(oVEMP) and Caloric Test. Methods: Randomized, prospective triple-blind, placebo controlled clinical trial. All participants underwent otoscopy, tympanometry, responded to the Profile of Mood State (POMS), submitted to the cVEMP, oVEMP and caloric tests. After that they received placebo or caffeine capsule (300mg) and repeated the procedures 45 minutes after.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsVertigo, Diseases, Vestibular, Caffeine

CountriesBrazil

Collaborators--

Timeline

Phase 4CompletedFinished

20162017201820192020202120222023202420252026

Enrollment StartFeb 2016

Primary CompletionApr 2016

Study CompletionMay 2016

First PostedJul 2016

TodayJul 2026

First PostedJul 7, 2016

Enrollment StartFeb 1, 2016

Primary CompletionApr 1, 2016

Study CompletionMay 1, 2016

TodayJul 2, 2026

Enrollment to primary: 2 monthsPosted 10.0 years ago

Interventions

Caffeinedietary

capsule: 300mg caffeine

Non caffeinedietary

capsule: placebo (maize starch)